Fundraising Fox

Spark Biomedical

Dallas, US · Founded 2023 · Delaware corporation · 2 known investors

sparkbiomedical.com

Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.

BiotechDigital HealthHardwareHealthtechMedical Devicesin /spark-biomedical-llc@sparkbiomedical

Founders & leadership

DPDaniel Powell
Daniel PowellinPresident & Chief Executive Officer
ACAlejandro Covalin, PhD
Alejandro Covalin, PhDinChief Technology Officer
NKNavid Khodaparast, PhD
Navid Khodaparast, PhDinChief Science Officer
AC
Alejandro CovalinChief Technology Officer and Director
NK
Navid KhodaparastChief Science Officer and Director
TC
Ted CostopoulosDirector
CR
Carl R. DeeleyDirector

Investors · 2

Reported raises · per SEC filings

Form D private placements
$16.2MraisedMay 2023 · 127 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alejandro CovalinExecutive Officer, Director
  • Navid KhodaparastExecutive Officer, Director
  • Ted CostopoulosDirector
  • Carl R. DeeleyDirector
  • Daniel PowellExecutive Officer, Director
Offering amount
$21.8M
Amount sold
$16.2M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news